278 related articles for article (PubMed ID: 29427759)
1. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.
Ma J; Sanda M; Wei R; Zhang L; Goldman R
J Proteomics; 2018 Oct; 189():67-74. PubMed ID: 29427759
[TBL] [Abstract][Full Text] [Related]
2. Optimized Fragmentation for Quantitative Analysis of Fucosylated N-Glycoproteins by LC-MS-MRM.
Yuan W; Wei R; Goldman R; Sanda M
Anal Chem; 2019 Jul; 91(14):9206-9212. PubMed ID: 31268672
[TBL] [Abstract][Full Text] [Related]
3. Analysis of site and structure specific core fucosylation in liver cirrhosis using exoglycosidase-assisted data-independent LC-MS/MS.
Sanda M; Ahn J; Kozlik P; Goldman R
Sci Rep; 2021 Dec; 11(1):23273. PubMed ID: 34857845
[TBL] [Abstract][Full Text] [Related]
4. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry.
Ji ES; Hwang H; Park GW; Lee JY; Lee HK; Choi NY; Jeong HK; Kim KH; Kim JY; Lee S; Ahn YH; Yoo JS
Anal Bioanal Chem; 2016 Nov; 408(27):7761-7774. PubMed ID: 27565792
[TBL] [Abstract][Full Text] [Related]
5. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
6. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P
J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713
[TBL] [Abstract][Full Text] [Related]
7. Computational classification of core and outer fucosylation of N-glycoproteins in human plasma using collision-induced dissociation in mass spectrometry.
Jeong HK; Hwang H; Kang YM; Lee HK; Park GW; Lee JY; Kim DG; Lee JW; Lee SY; An HJ; Kim JY; Yoo JS
Rapid Commun Mass Spectrom; 2020 Dec; 34(23):e8917. PubMed ID: 32754952
[TBL] [Abstract][Full Text] [Related]
8. Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease.
Benicky J; Sanda M; Pompach P; Wu J; Goldman R
Anal Chem; 2014 Nov; 86(21):10716-23. PubMed ID: 25302577
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning Classifies Core and Outer Fucosylation of N-Glycoproteins Using Mass Spectrometry.
Hwang H; Jeong HK; Lee HK; Park GW; Lee JY; Lee SY; Kang YM; An HJ; Kang JG; Ko JH; Kim JY; Yoo JS
Sci Rep; 2020 Jan; 10(1):318. PubMed ID: 31941975
[TBL] [Abstract][Full Text] [Related]
10. The analysis of alpha-1-antitrypsin glycosylation with direct LC-MS/MS.
Yin H; An M; So PK; Wong MY; Lubman DM; Yao Z
Electrophoresis; 2018 Sep; 39(18):2351-2361. PubMed ID: 29405331
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.
Yuan W; Sanda M; Wu J; Koomen J; Goldman R
J Proteomics; 2015 Feb; 116():24-33. PubMed ID: 25582524
[TBL] [Abstract][Full Text] [Related]
12. Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.
Zhu J; Chen Z; Zhang J; An M; Wu J; Yu Q; Skilton SJ; Bern M; Ilker Sen K; Li L; Lubman DM
J Proteome Res; 2019 Jan; 18(1):359-371. PubMed ID: 30370771
[TBL] [Abstract][Full Text] [Related]
13. Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS.
Lin Z; Yin H; Lo A; Ruffin MT; Anderson MA; Simeone DM; Lubman DM
Electrophoresis; 2014 Aug; 35(15):2108-15. PubMed ID: 24285556
[TBL] [Abstract][Full Text] [Related]
14. Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation.
Sanda M; Zhang L; Edwards NJ; Goldman R
Anal Bioanal Chem; 2017 Jan; 409(2):619-627. PubMed ID: 27822650
[TBL] [Abstract][Full Text] [Related]
15. A procedure for the analysis of site-specific and structure-specific fucosylation in alpha-1-antitrypsin.
Yin H; Zhu J; Wu J; Tan Z; An M; Zhou S; Mechref Y; Lubman DM
Electrophoresis; 2016 Oct; 37(20):2624-2632. PubMed ID: 27439567
[TBL] [Abstract][Full Text] [Related]
16. Protein and site specificity of fucosylation in liver-secreted glycoproteins.
Pompach P; Ashline DJ; Brnakova Z; Benicky J; Sanda M; Goldman R
J Proteome Res; 2014 Dec; 13(12):5561-9. PubMed ID: 25265424
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.
Yuan W; Benicky J; Wei R; Goldman R; Sanda M
J Proteome Res; 2018 Aug; 17(8):2755-2766. PubMed ID: 29972295
[TBL] [Abstract][Full Text] [Related]
18. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
19. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
[TBL] [Abstract][Full Text] [Related]
20. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
Naitoh A; Aoyagi Y; Asakura H
J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
